Neonatal thyrotoxicosis: Alterations in serum concentration of LATS-protector, T4, T3, reverse T3, and 3, 3′T2
- 31 July 1978
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 93 (1) , 118-120
- https://doi.org/10.1016/s0022-3476(78)80620-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A Radioimmunoassay for 3,3′-L-Diiodothyronine (3,3′T2)Journal of Clinical Endocrinology & Metabolism, 1977
- Measurements of 3,3′5′-Triiodothyronine (Reverse T3), 3,3′-L-Diiodothyronine, T3, and T4 in Human Amniotic Fluid and in Cord and Maternal Serum1 2Journal of Clinical Endocrinology & Metabolism, 1976
- 3,3′,5′-Triiodothyronine (Reverse T3) and 3,3′,5-Triiodothyronine)(T3) in Fetal and Adult Sheep: Studies of Metabolic Clearance) Rates, Production Rates, Serum Binding, and Thyroidal Content Relative to ThyroxineEndocrinology, 1975
- Placental transmission of thyroid-stimulating immunoglobulins.BMJ, 1975
- Circulating 3,3', 5'-triiodothyronine (reverse T3) in the human newborn.Journal of Clinical Investigation, 1975
- Stimulation of the Human Thyroid by Infusions of Plasma Containing LATS ProtectorJournal of Clinical Endocrinology & Metabolism, 1974
- Specific and Nonspecific Responses in the Bioassay of Long-Acting Thyroid Stimulator (LATS)Journal of Clinical Endocrinology & Metabolism, 1970
- A Fœtus with Congenital Hereditary Graves's Disease.BJOG: An International Journal of Obstetrics and Gynaecology, 1912